Diabetes & Metabolism

1. Diabetes Metab24 Oct 2025

   Patient-reported outcome measures (PROMs) are differently associated with treatment modalities, household income, and diabetes-related events in children with type 1 diabetes, their mothers, and their fathers: a French nationwide survey

   Cross-sectional studyTechnology

2. Diabetes Metab15 Oct 2025

   Management of patients with type 2 diabetes and MASLD: An overview and joint statement

   Guideline or statementT2D & other

3. Diabetes Metab8 Oct 2025

   Epicardial adipose tissue volume and diabetic retinopathy

   Cross-sectional studyComplications

4. Diabetes Metab18 Sep 2025

   Glycemic and renal effects of SGLT2 Inhibitors in Prader-Willi syndrome: Benefits and risks

   Cohort studyT2D & other

5. Diabetes Metab12 Sep 2025

   Diabetic retinopathy remission in patients using an automated insulin delivery system: A prospective controlled study

   Cohort studyComplications

6. Diabetes Metab10 Sep 2025

   Modelled substitution of meat with dairy products and the 20-year cumulative incidence of type 2 diabetes: Insights from the ATTICA cohort study (2002–2022)

   Cohort studyT2D & other

7. Diabetes Metab5 Sep 2025

   Incidence of death and amputation in patients with a first diabetic foot ulcer: results from the CODIA cohort

   Cohort studyComplications

8. Diabetes Metab27 Aug 2025

   Prevalence and predictive factors of computed tomography-detected pancreatopathy in a cohort of adult patients hospitalized for newly diagnosed or uncontrolled non-auto-immune diabetes

   Cohort studyT2D & other

9. Diabetes Metab22 Aug 2025

   SGLT2 inhibitors and the risk of hepatocellular carcinoma in patients with MASLD and Type 2 diabetes

   Cohort studyT2D & other

10. Diabetes Metab18 Aug 2025

    Ketoacidosis associated with type 2 sodium-glucose cotransporter inhibitors (SGLT2i) in patients aged 65 and older: Evidence from the French national pharmacovigilance database

    Cohort studyComplications

11. Diabetes Metab10 Aug 2025

    Reduced risks of colorectal cancer with GLP-1RAs in type 2 diabetes: A nationwide cohort study using a target trial emulation framework

    Cohort studyT2D & other

12. Diabetes Metab5 Aug 2025

    SGLT2 inhibitor and urothelial carcinoma incidence in type 2 diabetes patients

    Cohort studyT2D & other

13. Diabetes Metab29 Jul 2025

    Body weight trends in individuals with type 1 diabetes using automated insulin delivery vs. traditional insulin pumps

    Cohort studyTechnology

14. Diabetes Metab26 Jul 2025

    Association between smoking status and suicide mortality in patients with type 2 diabetes: A nationwide population-based cohort study

    Cohort studyT2D & other

15. Diabetes Metab24 Jul 2025

    Conduction disturbances in Type 1 and Type 2 Diabetes in two large independent nationwide and international databases

    Cohort studyComplications

16. Diabetes Metab23 Jul 2025

    Intact fish skin graft for deep diabetic foot ulcers: results from the KEREFISH randomized controlled trial

    Randomized controlled trialComplications

17. Diabetes Metab6 Jul 2025

    Exploring perceived barriers to physical activity among individuals with type 1 diabetes in the era of new technologies: An analysis from the BETTER registry

    Cross-sectional studyT1D

18. Diabetes Metab5 Jul 2025

    Association between continuous glucose monitoring metrics and metabolic dysfunction-associated steatotic liver disease in adults with type 1 diabetes undergoing vibration-controlled transient elastography: a multicenter cross-sectional study

    Cross-sectional studyT1D

19. Diabetes Metab23 Jun 2025

    Prediction of cardiovascular events by skin auto-fluorescence: the DIABAGE follow-up study

    Cohort studyT1D

20. Diabetes Metab21 Jun 2025

    The impact of chiglitazar, a pan-PPAR agonist, on metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes: a real-world study

    Cohort studyLipids & liver

21. Diabetes Metab20 Jun 2025

    In adults living with type 1 diabetes, additional autoimmune diseases are associated with more chronic complications and depression. A BETTER registry analysis

    Cross-sectional studyComplications

22. Diabetes Metab18 Jun 2025

    Mitochondrial heteroplasmy-phenotype correlation and response to glucose lowering therapy in subjects with m.3243A>G mutations

    Cohort studyT2D & other

23. Diabetes Metab9 Jun 2025

    Can diabetic peripheral neuropathy predict lacunar stroke in patients with diabetes?

    Cohort studyComplications

24. Diabetes Metab30 May 2025

    Cardiorenal outcomes and safety of SGLT2 inhibitors in patients with diabetes secondary to disorders of the exocrine pancreas: a nationwide population-based study

    Cohort studyT2D & other

25. Diabetes Metab16 May 2025

    The association of sweetened beverage intake with risk of type 2 diabetes in an Australian population: A longitudinal study

    Cohort studyT2D & other

26. Diabetes Metab13 May 2025

    Diabetes prevalence, awareness, and control in the United States, 2017-2023

    Cross-sectional studyT2D & other

27. Diabetes Metab8 May 2025

    Global Burden of type 2 diabetes in non-elderly individuals 1990 to 2021 and projections for 2050: a systematic analysis of the 2021 Global Burden of Disease

    Cohort studyT2D & other

28. Diabetes Metab6 May 2025

    Glucose management indicator: Do we need device-specific equations?

    Cohort studyTechnology

29. Diabetes Metab30 Apr 2025

    Methylamine metabolites and progression to kidney failure in type 2 diabetes: An Asian and European prospective study

    Cohort studyComplications

30. Diabetes Metab23 Apr 2025

    Musculoskeletal disorders in type 1 diabetes: Clinical phenotyping and associations with quality of life and glucose control - The French SFDT1 cohort study

    Cross-sectional studyT1D

31. Diabetes Metab21 Apr 2025

    Comparative study of SGLT2 inhibitors and metformin: Evaluating first-line therapies for dementia prevention in type 2 diabetes

    Cohort studyT2D & other

32. Diabetes Metab21 Apr 2025

    Hip fractures and type 2 diabetes in the elderly: Risk factors analysis of the Nedices cohort

    Cohort studyT2D & other

33. Diabetes Metab21 Apr 2025

    Automated insulin delivery after beta-cell replacement failure in people living with type 1 diabetes

    Cohort studyTechnology

34. Diabetes Metab18 Apr 2025

    Increased fatty acid-binding protein 4 levels are associated with the risk of developing retinopathy in type 2 diabetes mellitus patients

    Cross-sectional studyComplications

35. Diabetes Metab15 Apr 2025

    Management of diabetes in patients hospitalized for acute cardiac events: Joint position paper from the French Society of Cardiology and the French-speaking Diabetes Society

    Guideline or statementComplications

36. Diabetes Metab11 Apr 2025

    Impact of SGLT-2i on COPD exacerbations in patients with type 2 diabetes mellitus: A systematic review and meta-analysis

    Meta-analysisT2D & other

37. Diabetes Metab18 Mar 2025

    Screening for autoimmune atrophic gastritis by serum gastrin measurement in subjects with type 1 diabetes

    Diagnostic or prognostic studyT1D

38. Diabetes Metab16 Mar 2025

    Acute kidney injury is associated with liver-related events in patients with metabolic dysfunction-associated fatty liver disease

    Cohort studyLipids & liver

39. Diabetes Metab16 Mar 2025

    Persistent gaps in the implementation of lipid-lowering therapy in patients with established atherosclerotic cardiovascular disease: A French nationwide study

    Cross-sectional studyLipids & liver

40. Diabetes Metab10 Mar 2025

    Practical implementation of automated insulin delivery systems in 2025: A French position statement update

    Guideline or statementTechnology

All 190 Briefs in ExploreShowing Briefs 41–80 of 190, newest first